<?xml version="1.0" encoding="UTF-8"?>
<p>Compound 
 <bold>418</bold> was tested for antimicrobial activities against two human pathogens (
 <italic>E. coli</italic> and 
 <italic>S. aureus</italic>), seven aquatic bacteria (
 <italic>Aeromonas hydrophila</italic>, 
 <italic>Edwardsiella tarda</italic>, 
 <italic>Micrococcus luteus</italic>, 
 <italic>Pseudomonas aeruginosa</italic>, 
 <italic>Vibrio alginolyticus</italic>, 
 <italic>Vibrio harveyi</italic>, and 
 <italic>Vibrio parahaemolyticus</italic>). Compound 
 <bold>418</bold> exhibited inhibitory activity against 
 <italic>E. coli</italic>, and 
 <italic>S. aureus</italic> with same MIC values of 32 µg/mL. Positive control was chloramphenicol which with MIC values of 2 µg/mL and 1 µg/mL against 
 <italic>E. coli</italic>, and 
 <italic>S. aureus</italic> [
 <xref rid="B136-ijms-22-00959" ref-type="bibr">136</xref>].
</p>
